Schwab director awarded 1,280 stock options
Schwab Charles Corp director Charles A. Ruffel received a grant of nonqualified stock options covering 1,280 shares of common stock.
Rhea-AI Filing Summary
Schwab Charles Corp director Charles A. Ruffel received a grant of nonqualified stock options covering 1,280 shares of common stock. The options have an exercise price of $95.78 per share, vested immediately, and expire on July 1, 2036. According to the disclosure, the options were issued under the Directors' Deferred Compensation Plan II in lieu of cash director fees, leaving Ruffel with 1,280 options following this transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,280 shares
Grant/Award
1 txn
Insider
Ruffel Charles A.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Nonqualified Stock Option (right to buy) | 1,280 | $0.00 | $0.00 |
Holdings After Transaction:
Nonqualified Stock Option (right to buy) — 1,280 contracts (Direct)
Footnotes (2)
- F1. The option was received pursuant to the Directors' Deferred Compensation Plan II and vested immediately.
- F2. The option was received in lieu of cash compensation otherwise payable as director fees.
Key Figures
Option grant size: 1,280 options
Exercise price: $95.78 per share
Expiration date: July 1, 2036
+2 more
5 metrics
Option grant size
1,280 options
Nonqualified stock option grant to director Charles A. Ruffel
Exercise price
$95.78 per share
Exercise price of nonqualified stock options
Expiration date
July 1, 2036
Option expiration for director grant
Shares underlying options
1,280 shares
Common stock underlying the nonqualified stock options
Total options after grant
1,280 options
Total derivative securities held directly after transaction
Key Terms
Nonqualified Stock Option, Directors' Deferred Compensation Plan II, in lieu of cash compensation
3 terms
Nonqualified Stock Option financial
"Nonqualified Stock Option (right to buy)"
A nonqualified stock option (NQSO) is a company grant that gives an individual the right to buy shares at a set price but does not meet special tax rules for incentive stock options; when exercised the difference between the market price and the exercise price is treated as ordinary income for the recipient and as a tax-deductible expense for the company. It matters to investors because NQSOs affect an employee’s after-tax proceeds, the company’s reported expenses, and potential share dilution—think of it like a cash bonus that converts into stock but is taxed as regular pay when you take it.
Directors' Deferred Compensation Plan II financial
"The option was received pursuant to the Directors' Deferred Compensation Plan II"
in lieu of cash compensation financial
"The option was received in lieu of cash compensation otherwise payable as director fees."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SCHW director Charles A. Ruffel report?
Director Charles A. Ruffel reported receiving 1,280 nonqualified stock options in Schwab Charles Corp. The grant is a compensation award, not an open-market purchase, and represents options to buy common shares at a fixed exercise price in the future.
What are the key terms of Charles A. Ruffel’s SCHW option grant?
Ruffel’s grant covers 1,280 nonqualified stock options with an exercise price of $95.78 per share. The options vested immediately and are scheduled to expire on July 1, 2036, providing a long-dated right to purchase Schwab Charles Corp common stock.
Was the SCHW option grant to Charles A. Ruffel part of his director compensation?
Yes. The filing states the option was received under the Directors' Deferred Compensation Plan II. It was granted in lieu of cash compensation otherwise payable as director fees, effectively replacing a portion of his cash board pay with equity-linked compensation.
How many Schwab options does Charles A. Ruffel hold after this transaction?
After the reported grant, Ruffel holds 1,280 nonqualified stock options directly, according to the filing’s post-transaction balance. These options each relate to one share of Schwab Charles Corp common stock, all under the same $95.78 exercise price and July 1, 2036 expiration.
AI-generated analysis. How Rhea-AI works. Not financial advice.